This Week in Addiction Medicine from ASAM
By American Society of Addiction Medicine
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 100
Description
This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine. Intended to serve as an accompaniment to the ASAM Weekly newsletter or as a stand-alone resource, This Week covers recent publications in addiction medicine research.
| Episode | Date |
|---|---|
|
Lead: Alcohol use screening, brief intervention and referral to treatment cascade of care in the USA: Variation by alcohol use and socio-demographic characteristics
|
Nov 03, 2026 |
|
Lead: The effect of stimulant medications on symptom and treatment outcomes in adults with comorbid attention-deficit/ hyperactivity and substance use disorder: A systematic review and meta-analysis
|
Oct 27, 2026 |
|
Lead: Projected health and economic outcomes in people who inject drugs in the United States, 2025-2034: A modeling study
|
Oct 20, 2026 |
|
Lead: Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression
|
Oct 13, 2026 |
|
Lead: Cannabis use and cannabis use disorder among older adults in the USA
|
Oct 06, 2026 |
|
Lead: Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population-based interrupted time series study
|
Sep 29, 2026 |
|
Lead: Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024
|
Sep 22, 2026 |
|
Lead: US drug overdose deaths involving stimulants without opioids continued to rise in 2024
|
Sep 15, 2026 |
|
Lead: US drug overdose deaths that occurred in isolation, 2022–2024
|
Sep 09, 2026 |
|
Lead: Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians
|
Sep 03, 2026 |
|
Lead: Oral semaglutide for alcohol use disorder: A randomized clinical trial
|
Aug 25, 2026 |
|
Lead: Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic
|
Aug 18, 2026 |
|
Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction
|
Aug 11, 2026 |
|
Lead: 2025 National Survey on Drug Use and Health (NSDUH)
|
Aug 04, 2026 |
|
Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study
|
Jul 28, 2026 |
|
Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023
|
Jul 21, 2026 |
|
Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians
|
Jul 14, 2026 |
|
Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial
|
Jul 07, 2026 |
|
Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week
|
Jun 30, 2026 |
|
Lead: Social media use trajectories and substance use experimentation: A prospective cohort study
|
Jun 23, 2026 |
|
Lead: Benzodiazepine tapering: Evidence limitations and research recommendations
|
Jun 16, 2026 |
|
Lead: Tobacco industry contributions to the development of ultraprocessed food in the United States, 1985–2007: A case study of Lunchables
|
Jun 09, 2026 |
|
Lead: GLP-1 receptor agonist treatment and health outcomes in methadone-treated patients with opioid use disorder and diabetes
|
Jun 02, 2026 |
|
Lead: Methamphetamine use among adult patients presenting with acute coronary syndrome: A single‐center retrospective cohort study
|
May 27, 2026 |
|
Lead: Best practices for hospital-based initiation of medications for opioid use disorder: A consensus statement
|
May 19, 2026 |
|
Lead: Access to medications for opioid use disorder among veterans with homeless experience in permanent supportive housing
|
May 12, 2026 |
|
Lead: Medicaid Managed Care Plan Alignment With State Substance Use Disorder Treatment Coverage Requirements
|
May 05, 2026 |
|
Lead: Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series
|
Apr 28, 2026 |
|
Lead: A µ-opioid receptor superagonist analgesic with minimal adverse effects
|
Apr 21, 2026 |
|
Lead: Methadone Dose and Patient-Directed Discharge in Hospitalized Patients with Opioid Use Disorder
|
Apr 14, 2026 |
|
Lead: Do US Adults View Drug and Alcohol Addiction as a Health Condition?
|
Apr 07, 2026 |
|
Lead: Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications—a systematic review
|
Mar 31, 2026 |
|
Lead: Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis
|
Mar 24, 2026 |
|
Lead: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
|
Mar 17, 2026 |
|
Lead: Does the total consumption model apply to cannabis use?
|
Mar 12, 2026 |
|
Lead: Spirituality and Harmful or Hazardous Alcohol and Other Drug Use
|
Mar 03, 2026 |
|
Lead: Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
|
Feb 24, 2026 |
|
Lead: Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023
|
Feb 18, 2026 |
|
Lead: Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
|
Feb 10, 2026 |
|
Lead: Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities
|
Feb 03, 2026 |
|
Lead: Public Views About Opioid Overdose and People With Opioid Use Disorder
|
Jan 27, 2026 |
|
Lead: Did the illicit fentanyl trade experience a supply shock?
|
Jan 21, 2026 |
|
Lead: Barriers to Buprenorphine Initiation in Patients Using Fentanyl
|
Jan 13, 2026 |
|
Lead: Productivity Losses From Substance Use Disorder in the U.S. in 2023
|
Dec 16, 2025 |
|
Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
|
Dec 09, 2025 |
|
Lead: Very Low Nicotine Content Cigarettes for Smoking Cessation: Examining a Facilitated Extinction Approach and Dosing Schedule
|
Dec 02, 2025 |
|
Lead: Fatal Opioid Overdoses by Historical and Contemporary Neighborhood-Level Structural Racism
|
Nov 25, 2025 |
|
Lead: State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23
|
Nov 18, 2025 |
|
Lead: Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine
|
Nov 11, 2025 |
|
Lead: States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24
|
Nov 04, 2025 |
|
Lead: Ultra-processed food addiction in a nationally representative sample of older adults in the USA
|
Oct 28, 2025 |
|
Lead: Alcohol Consumption Per Capita and Suicide: A Meta-Analysis
|
Oct 21, 2025 |
|
Lead: Measures of General Intelligence and Risk for Alcohol Use Disorder
|
Oct 14, 2025 |
|
Lead: Medications for Opioid Use Disorder Playbook
|
Oct 11, 2025 |
|
Lead: Cannabis Use During Pregnancy and Lactation
|
Sep 30, 2025 |
|
Lead: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study
|
Sep 23, 2025 |
|
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound
|
Sep 16, 2025 |
|
Lead: Evaluation of a Novel Patient-Centered Methadone Restart Protocol
|
Sep 09, 2025 |
|
Lead: Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process
|
Sep 02, 2025 |
|
Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting
|
Aug 26, 2025 |
|
Lead: Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD
|
Aug 19, 2025 |
|
Lead: Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial
|
Aug 12, 2025 |
|
Lead: Implementation Gaps in US Syringe Service Programs, 2022
|
Aug 05, 2025 |
|
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’
|
Jul 29, 2025 |
|
Lead: Did alcohol facilitate the evolution of complex societies?
|
Jul 22, 2025 |
|
Lead: Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients
|
Jul 15, 2025 |
|
Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
|
Jul 08, 2025 |
|
Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits
|
Jun 24, 2025 |
|
Lead: Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
|
Jun 17, 2025 |
|
Lead: Bitter sensing protects Drosophila from developing experience-dependent cocaine consumption preference
|
Jun 10, 2025 |
|
Lead: Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons
|
Jun 02, 2025 |
|
Lead: Medicaid Unwinding and Changes in Buprenorphine Dispensing
|
May 28, 2025 |
|
Lead: Loneliness Among US Veterans With Problematic Substance Use: Results From the National Health and Resilience in Veterans Study
|
May 20, 2025 |
|
Lead: The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption
|
May 13, 2025 |
|
Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols
|
May 06, 2025 |
|
Lead: Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial
|
Apr 29, 2025 |
|
Lead: Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties
|
Apr 22, 2025 |
|
Lead: Hospital Addiction Consultation Service and Opioid Use Disorder Treatment
|
Apr 15, 2025 |
|
Lead: Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022
|
Apr 08, 2025 |
|
Lead: Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years
|
Apr 01, 2025 |
|
Lead: Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans
|
Mar 25, 2025 |
|
Lead: Association Between Telehealth Initiation Of Stimulant Therapy And New Substance Use Disorder Diagnoses
|
Mar 18, 2025 |
|
Lead: The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021
|
Mar 11, 2025 |
|
Lead: Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness
|
Mar 04, 2025 |
|
Lead: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
|
Feb 25, 2025 |
|
Lead: Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
|
Feb 19, 2025 |
|
Lead: Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders
|
Feb 11, 2025 |
|
Lead: Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
|
Feb 04, 2025 |
|
Lead: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
|
Jan 28, 2025 |
|
Lead: Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice
|
Jan 21, 2025 |
|
ASAM Weekly Special Episode: Dr. David Fiellin & Dr. Eric Strain sit down to discuss the concept of Treatment Refractory Addiction
|
Jan 14, 2025 |
|
Lead: Review of Evidence on Alcohol and Health
|
Jan 14, 2025 |
|
Lead: The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
|
Dec 17, 2024 |
|
Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students
|
Dec 10, 2024 |
|
Lead: Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine
|
Dec 04, 2024 |
|
Lead: Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study
|
Nov 19, 2024 |
|
Lead: Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity
|
Nov 05, 2024 |
|
Lead: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
|
Oct 29, 2024 |
|
Lead: Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
|
Oct 22, 2024 |
|
Lead: Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review
|
Oct 15, 2024 |